Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101 crores in Q4FY23.
Jubilant Pharmova Q4FY23; Reported Losses
Tags: Radiopharma
Related Post
- Titan Company Ltd Q2FY25; 1.5% fall in Net Profits
Company Overview: Titan Company Ltd is among India’s most respected lifestyle companies. It has established…
-
Coal India Ltd Q2FY25; 22% fall in Profits
Coal India Ltd is mainly engaged in mining and production of Coal and also operates…
-
Cholamandalam Investment & Finance Company Ltd Q2FY25; 25% rise in Profits
Cholamandalam Investment & Finance Company is one of the premier diversified non-banking finance companies in…